Please enable JavaScript to continue using this application.

Compare $CRBU vs $HOWL | Chartloom

Compare

$CRBU vs $HOWL

Caribou Biosciences Inc · Werewolf Therapeutics Inc

CRBU

Caribou Biosciences Inc

HOWL

Werewolf Therapeutics Inc

Compare $CRBU vs $HOWL

Comparing Caribou Biosciences Inc and Werewolf Therapeutics Inc

CRBUCaribou Biosciences Inc

HOWLWerewolf Therapeutics Inc

CRBUCaribou Biosciences Inc

Market cap

$46M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

10.0%

YTD performance

-71.1%

52W performance

-82.8%

FCF yield

-210.7%

HOWLWerewolf Therapeutics Inc

Market cap

$48M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

51.9%

52W performance

-47.9%

FCF yield

-63.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRBU

HOWL

Detailed metrics comparison

CRBU

Caribou Biosciences Inc

HOWL

Werewolf Therapeutics Inc

Market Cap

CRBU$46M

HOWL$48M

Enterprise Value

CRBU$19M

HOWL$26M

Price

CRBU$0.46

HOWL$0.98

P/E Ratio

CRBUN/A

HOWLN/A

P/S Ratio

CRBU4.55x

HOWL2.27x

EV/Sales

CRBU1.94x

HOWL1.22x

EV/EBITDA

CRBU0.00x

HOWL0.00x

P/B Ratio

CRBU1.33x

HOWL2.77x

P/FCF Ratio

CRBUN/A

HOWLN/A

EV/FCF

CRBU-0.20x

HOWL-0.85x

PEG Ratio

CRBUN/A

HOWLN/A

Forward P/E (NTM)

CRBUN/A

HOWLN/A

Forward P/S (NTM)

CRBUN/A

HOWLN/A

Revenue (TTM)

CRBU$10M

HOWL$21M

Revenue Growth (YoY)

CRBU10.0%

HOWLN/A

Forward Rev Growth

CRBU15.8%

HOWL0.0%

Gross Margin (TTM)

CRBU0.0%

HOWL0.0%

Operating Margin (TTM)

CRBU0.0%

HOWL18.1%

EBITDA Margin (TTM)

CRBU-1065.1%

HOWL-104.4%

Net Margin (TTM)

CRBU-1030.4%

HOWL-164.8%

FCF Margin (TTM)

CRBU-958.5%

HOWL-143.6%

Net Income (TTM)

CRBU$-103M

HOWL$-35M

FCF (TTM)

CRBU$-96M

HOWL$-30M

EPS (TTM)

CRBU-$1.02

HOWL-$0.71

ROE (TTM)

CRBU-8911.0%

HOWL-16698.0%

ROA (TTM)

CRBU-6247.0%

HOWL-5988.0%

ROIC (TTM)

CRBU-8911.0%

HOWL-8259.0%

Cash

CRBU$26M

HOWL$22M

Debt

CRBU$0

HOWL$0

Net Cash/Debt

CRBU$26M

HOWL$22M

Current Ratio (TTM)

CRBU6.49x

HOWL2.91x

Quick Ratio (TTM)

CRBU6.36x

HOWL2.80x

Debt/Equity (TTM)

CRBU0.00x

HOWL1.14x

Debt/Assets (TTM)

CRBU0.0%

HOWL0.0%

Interest Coverage (TTM)

CRBUN/A

HOWLN/A

Net Debt/EBITDA (TTM)

CRBU0.00x

HOWL0.00x

Beta

CRBU2.46

HOWL0.57

52W Performance

CRBU-82.8%

HOWL-47.9%

YTD Performance

CRBU-71.1%

HOWL51.9%

% from 52W High

CRBU-87.0%

HOWL-49.4%

% from 52W Low

CRBU4.0%

HOWL262.8%

Asset Turnover (TTM)

CRBU0.06x

HOWL0.87x

FCF Yield (TTM)

CRBU-210.7%

HOWL-63.3%

Earnings Yield (TTM)

CRBU-226.5%

HOWL-72.7%

Dividend Yield (TTM)

CRBUN/A

HOWLN/A

Rule of 40

CRBU-948.5

HOWL-143.6

EV/GP/RG

CRBUN/A

HOWLN/A

Ticker research

View CRBU research View HOWL research

Metric	CRBU Caribou Biosciences Inc	HOWL Werewolf Therapeutics Inc
Market & Valuation
Market Cap	$46M	$48M
Enterprise Value	$19M	$26M
Price	$0.46	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	4.55x	2.27x
EV/Sales	1.94x	1.22x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.33x	2.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.20x	-0.85x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$10M	$21M
Revenue Growth (YoY)	10.0%	N/A
Forward Rev Growth	15.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	18.1%
EBITDA Margin (TTM)	-1065.1%	-104.4%
Net Margin (TTM)	-1030.4%	-164.8%
FCF Margin (TTM)	-958.5%	-143.6%
Net Income (TTM)	$-103M	$-35M
FCF (TTM)	$-96M	$-30M
EPS (TTM)	-$1.02	-$0.71
ROE (TTM)	-8911.0%	-16698.0%
ROA (TTM)	-6247.0%	-5988.0%
ROIC (TTM)	-8911.0%	-8259.0%
Financial Health
Cash	$26M	$22M
Debt	$0	$0
Net Cash/Debt	$26M	$22M
Current Ratio (TTM)	6.49x	2.91x
Quick Ratio (TTM)	6.36x	2.80x
Debt/Equity (TTM)	0.00x	1.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.46	0.57
52W Performance	-82.8%	-47.9%
YTD Performance	-71.1%	51.9%
% from 52W High	-87.0%	-49.4%
% from 52W Low	4.0%	262.8%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.87x
FCF Yield (TTM)	-210.7%	-63.3%
Earnings Yield (TTM)	-226.5%	-72.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-948.5	-143.6
EV/GP/RG	N/A	N/A
Ticker research	View CRBU research	View HOWL research

Valuation

P/S Ratio

HOWL

2.27x

CRBU

4.55x

EV/FCF

HOWL

-0.85x

CRBU

-0.20x

Growth & revenue

Revenue Growth TTM

CRBU

10.0%

Forward Revenue Growth

CRBU

15.8%

HOWL

0.0%

Profitability & performance

Gross Margin

CRBU

0.0%

HOWL

0.0%

ROE

CRBU

-8911.0%

HOWL

-16698.0%

FCF Yield %

HOWL

-63.3%

CRBU

-210.7%

52-Week Performance

HOWL

-47.9%

CRBU

-82.8%

Detailed metrics comparison

CRBU

Caribou Biosciences Inc

HOWL

Werewolf Therapeutics Inc

Market Cap

CRBU$46M

HOWL$48M

Enterprise Value

CRBU$19M

HOWL$26M

Price

CRBU$0.46

HOWL$0.98

P/E Ratio

CRBUN/A

HOWLN/A

P/S Ratio

CRBU4.55x

HOWL2.27x

EV/Sales

CRBU1.94x

HOWL1.22x

EV/EBITDA

CRBU0.00x

HOWL0.00x

P/B Ratio

CRBU1.33x

HOWL2.77x

P/FCF Ratio

CRBUN/A

HOWLN/A

EV/FCF

CRBU-0.20x

HOWL-0.85x

PEG Ratio

CRBUN/A

HOWLN/A

Forward P/E (NTM)

CRBUN/A

HOWLN/A

Forward P/S (NTM)

CRBUN/A

HOWLN/A

Revenue (TTM)

CRBU$10M

HOWL$21M

Revenue Growth (YoY)

CRBU10.0%

HOWLN/A

Forward Rev Growth

CRBU15.8%

HOWL0.0%

Gross Margin (TTM)

CRBU0.0%

HOWL0.0%

Operating Margin (TTM)

CRBU0.0%

HOWL18.1%

EBITDA Margin (TTM)

CRBU-1065.1%

HOWL-104.4%

Net Margin (TTM)

CRBU-1030.4%

HOWL-164.8%

FCF Margin (TTM)

CRBU-958.5%

HOWL-143.6%

Net Income (TTM)

CRBU$-103M

HOWL$-35M

FCF (TTM)

CRBU$-96M

HOWL$-30M

EPS (TTM)

CRBU-$1.02

HOWL-$0.71

ROE (TTM)

CRBU-8911.0%

HOWL-16698.0%

ROA (TTM)

CRBU-6247.0%

HOWL-5988.0%

ROIC (TTM)

CRBU-8911.0%

HOWL-8259.0%

Cash

CRBU$26M

HOWL$22M

Debt

CRBU$0

HOWL$0

Net Cash/Debt

CRBU$26M

HOWL$22M

Current Ratio (TTM)

CRBU6.49x

HOWL2.91x

Quick Ratio (TTM)

CRBU6.36x

HOWL2.80x

Debt/Equity (TTM)

CRBU0.00x

HOWL1.14x

Debt/Assets (TTM)

CRBU0.0%

HOWL0.0%

Interest Coverage (TTM)

CRBUN/A

HOWLN/A

Net Debt/EBITDA (TTM)

CRBU0.00x

HOWL0.00x

Beta

CRBU2.46

HOWL0.57

52W Performance

CRBU-82.8%

HOWL-47.9%

YTD Performance

CRBU-71.1%

HOWL51.9%

% from 52W High

CRBU-87.0%

HOWL-49.4%

% from 52W Low

CRBU4.0%

HOWL262.8%

Asset Turnover (TTM)

CRBU0.06x

HOWL0.87x

FCF Yield (TTM)

CRBU-210.7%

HOWL-63.3%

Earnings Yield (TTM)

CRBU-226.5%

HOWL-72.7%

Dividend Yield (TTM)

CRBUN/A

HOWLN/A

Rule of 40

CRBU-948.5

HOWL-143.6

EV/GP/RG

CRBUN/A

HOWLN/A

Ticker research

View CRBU research View HOWL research

Metric	CRBU Caribou Biosciences Inc	HOWL Werewolf Therapeutics Inc
Market & Valuation
Market Cap	$46M	$48M
Enterprise Value	$19M	$26M
Price	$0.46	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	4.55x	2.27x
EV/Sales	1.94x	1.22x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.33x	2.77x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.20x	-0.85x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$10M	$21M
Revenue Growth (YoY)	10.0%	N/A
Forward Rev Growth	15.8%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	18.1%
EBITDA Margin (TTM)	-1065.1%	-104.4%
Net Margin (TTM)	-1030.4%	-164.8%
FCF Margin (TTM)	-958.5%	-143.6%
Net Income (TTM)	$-103M	$-35M
FCF (TTM)	$-96M	$-30M
EPS (TTM)	-$1.02	-$0.71
ROE (TTM)	-8911.0%	-16698.0%
ROA (TTM)	-6247.0%	-5988.0%
ROIC (TTM)	-8911.0%	-8259.0%
Financial Health
Cash	$26M	$22M
Debt	$0	$0
Net Cash/Debt	$26M	$22M
Current Ratio (TTM)	6.49x	2.91x
Quick Ratio (TTM)	6.36x	2.80x
Debt/Equity (TTM)	0.00x	1.14x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.46	0.57
52W Performance	-82.8%	-47.9%
YTD Performance	-71.1%	51.9%
% from 52W High	-87.0%	-49.4%
% from 52W Low	4.0%	262.8%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.87x
FCF Yield (TTM)	-210.7%	-63.3%
Earnings Yield (TTM)	-226.5%	-72.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-948.5	-143.6
EV/GP/RG	N/A	N/A
Ticker research	View CRBU research	View HOWL research